[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341218-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341218-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-humanized-trivalent-nectin-4-targeting-nanobody-drug-conjugate-displays-potent-antitumor-activity-in-gastric-cancer","A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer","","Nectin-4 is an overexpressed oncology target, and antibody-drug conjugates (ADCs) have been used to treat solid tumors; however, IgG-based ADCs face binding-site barriers, and limited work targets Nectin-4 specifically in gastric cancer. To address this, the study develops Nectin-4-targeting nanobody drug conjugates (NDCs). Using immunized phage display, Nectin-4-specific nanobodies are selected and engineered into homodimers to improve affinity. A human serum albumin fusion yields trivalent humanized nanobodies, and site-specific conjugation of MMAE produces huNb26/Nb26-Nbh-MMAE with a DAR of 1. The conjugate shows strong in vitro binding and cytotoxicity against high-Nectin-4 cells, and in vivo imaging demonstrates rapid penetration and high tumor uptake in gastric cancer xenografts, with dose-dependent antitumor efficacy and enhanced therapeutic potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-humanized-trivalent-nectin-4-targeting-nanobody-drug-conjugate-displays-potent-antitumor-activity-in-gastric-cancer/341218/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-humanized-trivalent-nectin-4-targeting-nanobody-drug-conjugate-displays-potent-antitumor-activity-in-gastric-cancer/341218.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are Nectin-4 ADCs difficult to develop using IgG-based formats for gastric cancer?","Question",{"text":63,"@type":64},"Conventional IgG-based ADCs often encounter binding-site barriers, which limits effective interaction with the target in solid tumors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the Nectin-4-targeting nanobodies generated and optimized?",{"text":68,"@type":64},"An immunized phage display library was used to select Nectin-4-specific nanobodies, which were then engineered into homodimers to enhance affinity.",{"name":70,"@type":61,"acceptedAnswer":71},"What conjugation strategy was used to create the final Nectin-4 NDC, and what payload ratio was achieved?",{"text":72,"@type":64},"A humanized trivalent nanobody platform was fused with human serum albumin and then site-specifically conjugated with MMAE at the C-terminus, yielding a DAR of 1.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341218,1790174767,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":26,"preview_urls":147},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Wu et al. Journal of Nanobiotechnology (2024) 22:256  \n[https://doi.org/10.1186/s12951-024-02521-5](https://doi.org/10.1186/s12951-024-02521-5)  \nJournal of Nanobiotechnology  \nRESEARCH Open Access  \nA humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer  \nYue Wu 1,2†, Min Zhu3†, Baihe Sun 1,2, Yongting Chen4, Yuping Huang3, Junwei Gai3, Guanghui Li3, Yanfei Li 1,2*, Yakun Wan3* and Linlin Ma 1,2*  \nAbstract  \nBackground Gastric cancer represents a highly lethal malignancy with an elevated mortality rate among cancer patients, coupled with a suboptimal postoperative survival prognosis. Nectin-4, an overexpressed oncological target for various cancers, has been exploited to create antibody-drug conjugates (ADCs) to treat solid tumors. However, there is limited research on Nectin-4 ADCs specifically for gastric cancer, and conventional immunoglobulin G (IgG) -based ADCs frequently encounter binding site barriers. Based on the excellent tumor penetration capabilities inherent in nanobodies (Nbs), we developed Nectin-4-targeting Nb drug conjugates (NDCs) for the treatment of gastric cancer. Results An immunized phage display library was established and employed for the selection of Nectin-4-specific Nbs using phage display technology. Subsequently, these Nbs were engineered into homodimers to enhance Nb affinity. To prolong in vivo half-life and reduce immunogenicity, we fused an Nb targeting human serum albumin (HSA), resulting in the development of trivalent humanized Nbs. Further, we site-specifically conjugated a monomethyl auristatin E (MMAE) at the C-terminus of the trivalent Nbs, creating Nectin-4 NDC (huNb26/Nb26-Nbh-MMAE) with a drug-to-antibody ratio (DAR) of 1. Nectin-4 NDC demonstrated excellent in vitro cell-binding activities and cytotoxic efficacy against cells with high Nectin-4 expression. Subsequent administration of Nectin-4 NDC to mice bearing NCIN87 human gastric cancer xenografts demonstrated rapid tissue penetration and high tumor uptake through in vivo imaging. Moreover, Nectin-4 NDC exhibited noteworthy dose-dependent anti-tumor efficacy in in vivo studies. Conclusion We have engineered a Nectin-4 NDC with elevated affinity and effective tumor uptake, further establishing its potential as a therapeutic agent for gastric cancer.  \n†Yue Wu and Min Zhu contribute equally.  \n*Correspondence:  \nYanfei Li[liyf@sumhs.edu.cn](liyf@sumhs.edu.cn)[ ](liyf@sumhs.edu.cn)Yakun Wan[ykwan@novamab.com](ykwan@novamab.com)[ ](ykwan@novamab.com)Linlin Ma[linlinma1986@gmail.com](linlinma1986@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nWu et al. Journal of Nanobiotechnology (2024) 22:256 Page 2 of 15  \nGraphical abstract  \nKeywords Nectin-4, Nanobody drug conjugates, Gastric c","cbCaivA4RyBNkpTI","https://ap.wps.com/l/cbCaivA4RyBNkpTI","pdf",12981379,15,"English","# Abstract\n## Background\n## Results\n## Conclusion\n# Introduction\n## Gastric cancer context and targeted therapy\n## Nectin-4 biology and therapeutic targeting\n## Current clinical relevance","[{\"question\":\"Why are Nectin-4 ADCs difficult to develop using IgG-based formats for gastric cancer?\",\"answer\":\"Conventional IgG-based ADCs often encounter binding-site barriers, which limits effective interaction with the target in solid tumors.\"},{\"question\":\"How were the Nectin-4-targeting nanobodies generated and optimized?\",\"answer\":\"An immunized phage display library was used to select Nectin-4-specific nanobodies, which were then engineered into homodimers to enhance affinity.\"},{\"question\":\"What conjugation strategy was used to create the final Nectin-4 NDC, and what payload ratio was achieved?\",\"answer\":\"A humanized trivalent nanobody platform was fused with human serum albumin and then site-specifically conjugated with MMAE at the C-terminus, yielding a DAR of 1.\"}]","A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer | PDF",1790040984,38,[148,152],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/3b5237565a6e2fdeeb16c1bc33e8a0b5.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/dd97843e0866cf9cd3770aa581c5c7fb.webp",982,1309]